151 related articles for article (PubMed ID: 28486557)
1. Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
Ohno Y; Koizumi M; Nakayama H; Watanabe T; Hirooka M; Tokumoto Y; Kuroda T; Abe M; Fukuda S; Higashiyama S; Kumagi T; Hiasa Y
PLoS One; 2017; 12(5):e0177343. PubMed ID: 28486557
[TBL] [Abstract][Full Text] [Related]
2. M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression.
Hasan Z; Ashraf M; Tayyebi A; Hussain R
BMC Microbiol; 2006 Sep; 6():78. PubMed ID: 16978419
[TBL] [Abstract][Full Text] [Related]
3. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
4. ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma.
Liu X; He Y; Wang P; Hu J; Hao C; Wang Q; Yang Y; Sun Y; Ma B; Sun H; Xue D; Meng X
Dis Markers; 2022; 2022():5791471. PubMed ID: 35280441
[TBL] [Abstract][Full Text] [Related]
5. Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma.
Yang SL; Liu LP; Niu L; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
Oncotarget; 2016 Jun; 7(23):34571-81. PubMed ID: 27119229
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.
Li CX; Shen SM; Wang LS; Yu Y
Mol Med Rep; 2015 Apr; 11(4):2813-8. PubMed ID: 25483709
[TBL] [Abstract][Full Text] [Related]
7. ZNF689 suppresses apoptosis of hepatocellular carcinoma cells through the down-regulation of Bcl-2 family members.
Shigematsu S; Fukuda S; Nakayama H; Inoue H; Hiasa Y; Onji M; Higashiyama S
Exp Cell Res; 2011 Aug; 317(13):1851-9. PubMed ID: 21624362
[TBL] [Abstract][Full Text] [Related]
8. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells.
Shen SM; Yu Y; Wu YL; Cheng JK; Wang LS; Chen GQ
Carcinogenesis; 2010 Mar; 31(3):419-26. PubMed ID: 20015864
[TBL] [Abstract][Full Text] [Related]
11. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
12. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ
Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma.
Cheng S; Luo M; Ding C; Peng C; Lv Z; Tong R; Xiao H; Xie H; Zhou L; Wu J; Zheng S
Gene; 2016 Oct; 591(1):236-244. PubMed ID: 27397650
[TBL] [Abstract][Full Text] [Related]
15. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
Moon WS; Tarnawski AS
Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813
[TBL] [Abstract][Full Text] [Related]
16. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
17. Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) contributes to retinoic acid-induced differentiation of leukemic cells.
Yu Y; Shen SM; Zhang FF; Wu ZX; Han B; Wang LS
Biochem Biophys Res Commun; 2012 Jul; 423(4):721-5. PubMed ID: 22705300
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
19. Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma.
Gai X; Tu K; Li C; Lu Z; Roberts LR; Zheng X
Cell Death Dis; 2015 Apr; 6(4):e1712. PubMed ID: 25855960
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
